Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Wyllie

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|July 17, 2013
The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral LeishmaniasisStephen Patterson, Susan Wyllie, Laste Stojanovski, et al.
Plos Pathogens|July 11, 2024
Sterol 14-alpha demethylase (CYP51) activity in Leishmania donovani is likely dependent upon cytochrome P450 reductase 1Lindsay B Tulloch, Michele Tinti, Richard J Wall, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2022
High-Throughput Screening Platform To Identify Inhibitors of Protein Synthesis with Potential for the Treatment of MalariaFabio Tamaki, Fabio Fisher, Rachel Milne, et al.
The Journal of Biological Chemistry|October 16, 2009
Chemical validation of trypanothione synthetase: a potential drug target for human trypanosomiasisLeah S Torrie, Susan Wyllie, Daniel Spinks, et al.
Antimicrobial Agents and Chemotherapy|May 31, 2018
Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition MetalsRichard J Wall, Sonia Moniz, Michael G Thomas, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Synthesis of Nitrostyrylthiazolidine-2,4-dione Derivatives Displaying Antileishmanial PotentialOmar Khoumeri, Sébastien Hutter, Nicolas Primas, et al.
Frontiers in Cellular and Infection Microbiology|August 21, 2023
Mode of action studies confirm on-target engagement of lysyl-tRNA synthetase inhibitor and lead to new selection marker for <i>Cryptosporidium</i>Jack C Hanna, Victor Corpas-Lopez, Simona Seizova, et al.
Bioorganic & Medicinal Chemistry|January 24, 2012
Quinol derivatives as potential trypanocidal agentsAmy Capes, Stephen Patterson, Susan Wyllie, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2013
Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assayManu De Rycker, Irene Hallyburton, John Thomas, et al.
Microorganisms|July 2, 2021
Identification of Resistance Determinants for a Promising Antileishmanial Oxaborole SeriesMagali Van den Kerkhof, Philippe Leprohon, Dorien Mabille, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|July 17, 2013
The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral LeishmaniasisStephen Patterson, Susan Wyllie, Laste Stojanovski, et al.
Plos Pathogens|July 11, 2024
Sterol 14-alpha demethylase (CYP51) activity in Leishmania donovani is likely dependent upon cytochrome P450 reductase 1Lindsay B Tulloch, Michele Tinti, Richard J Wall, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2022
High-Throughput Screening Platform To Identify Inhibitors of Protein Synthesis with Potential for the Treatment of MalariaFabio Tamaki, Fabio Fisher, Rachel Milne, et al.
The Journal of Biological Chemistry|October 16, 2009
Chemical validation of trypanothione synthetase: a potential drug target for human trypanosomiasisLeah S Torrie, Susan Wyllie, Daniel Spinks, et al.
Antimicrobial Agents and Chemotherapy|May 31, 2018
Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition MetalsRichard J Wall, Sonia Moniz, Michael G Thomas, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Synthesis of Nitrostyrylthiazolidine-2,4-dione Derivatives Displaying Antileishmanial PotentialOmar Khoumeri, Sébastien Hutter, Nicolas Primas, et al.
Frontiers in Cellular and Infection Microbiology|August 21, 2023
Mode of action studies confirm on-target engagement of lysyl-tRNA synthetase inhibitor and lead to new selection marker for <i>Cryptosporidium</i>Jack C Hanna, Victor Corpas-Lopez, Simona Seizova, et al.
Bioorganic & Medicinal Chemistry|January 24, 2012
Quinol derivatives as potential trypanocidal agentsAmy Capes, Stephen Patterson, Susan Wyllie, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2013
Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assayManu De Rycker, Irene Hallyburton, John Thomas, et al.
Microorganisms|July 2, 2021
Identification of Resistance Determinants for a Promising Antileishmanial Oxaborole SeriesMagali Van den Kerkhof, Philippe Leprohon, Dorien Mabille, et al.
Pageof 10